Sovaprevir
- Generic Name
- Sovaprevir
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C43H53N5O8S
- CAS Number
- 1001667-23-7
- Unique Ingredient Identifier
- 2ND9V3MN6O
- Background
Sovaprevir has been investigated for the treatment of Hepatitis C, Chronic.
- Associated Conditions
- -
- Associated Therapies
- -
Safety, Tolerability, and Efficacy of 12-weeks of Sovaprevir, ACH-3102, and Ribavirin in Treatment-naive GT-1 HCV Participants
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2013-05-08
- Last Posted Date
- 2023-08-29
- Lead Sponsor
- Alexion Pharmaceuticals, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT01849562
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath